Serum C-reactive protein: A predictor of mortality in continuous ambulatory peritoneal dialysis patients

Peritoneal Dialysis International

Volumn 18, Issue 4, 1998, Pages 387-394

  Noh, Hyunjin ^a   Lee, Seoung Woo ^b   Kang, Shin Wook ^a   Shin, Sug Kyun ^a   Choi, Kyu Hun ^a   Lee, Ho Yung ^a   Han, Dae Suk ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Inha University School of Medicine   (South Korea)

Author keywords

C reactive protein; Mortality

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CREATININE CLEARANCE; DIABETES MELLITUS; FEMALE; FOLLOW UP; GENDER; HEMATOCRIT; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERITONITIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STATISTICAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031790338     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089801800407     Document Type: Article

References (46)

1. Harnett JD, Kent GM, Foley RN, Parfrey PS. Cardiac function and hematocrit level. Am J Kidney Dis 1995; 25(Suppl l):S3-7.
2. Goldwasser P, Mittnian N, Antignani A, Burrell D, Michel MA, Collier J, et al. Predictors of mortality in hemodialysis patients. J Am Soc Nephrol 1993; 3(9):1613-22.
3. Avram MM, Mittman N, Bonomini L, Chattopadhyay J, Fein P. Markers for survival in dialysis: a seven year prospective study. Am J Kidney Dis 1995; 26(1):209-19.
4. Mittman N, Avram MM, Bonomini L, Oo K, Licht J, Sreedhara R. Hemodialysis (HD) treatment dose is an independent determinant of seven year survival (Abstract). J Am Soc Nephrol 1995; 6:610.
5. Lowrie EG, Lew NL. Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 1990; 15(5):458-82.
6. Owen Jr WF, Lew NL, Liu Y, Lowrie EG, Lazarus JM. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med 1993; 329(14):1001-6.
7. Sreedhara R, Avram MM, Blanco M, Batish R, Avram MM, Mittman N. Prealbumin is the best nutritional predictor of survival in hemodialysis and peritoneal dialysis. Am J Kidney Dis 1996; 28(6):937-42.
8. Avram MM, Bonomini LV, Sreedhara R, Mittman N. Predictive value of nutritional markers (albumin, creatinine, cholesterol, and hematocrit) for patients on dialysis for up to 30 years. Am J Kidney Dis 1996; 28(6):910-17.
9. Bergström J, Heimbürger O, Lindholm B, Qureshi AR. Elevated serum C-reactive protein is a strong predictor of increased mortality and low serum albumin in hemodialysis (HD) patients (Abstract). J Am Soc Nephrol 1995; 6:573.
10. Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, et al. Factors affecting low values of serum albumin in CAPD patients. In: Khanna R, ed. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Publications, 1996; 12:288-92.
11. Keshaviah PR, Nolph KD, Moore HL, Prowant B, Emerson PF, Meyer M, et al. Lean body mass estimation by creatinine kinetics. J Am Soc Nephrol 1994; 4:1475-85.
12. Acchiardo SR, Moore LW, Latour PA. Malnutrition as the main factor in morbidity and mortality of dialysis patients. Kidney Int 1983; 24(Suppl 16):S199-203.
13. Winchester JF. The albumin dilemma (Editorial). Am J Kidney Dis 1992; 20(1):76-7.
14. Kopple JD. Effect of nutrition on morbidity and mortality in maintenance dialysis patients. Am J Kidney Dis 1994; 24(6):1002-9.
15. Bergström J. Nutrition and mortality in hemodialysis (Editorial). J Am Soc Nephrol 1995; 6(5):1329-41.
16. Churchill DN, Taylor DW, Cook RJ, LaPlante P, Barre P, Cartier P, et al. Canadian hemodialysis morbidity study. Am J Kidney Dis 1992; 19(3):214-34.
17. Blake PG, Flowerdew G, Blake RM, Oreopoulos DG. Serum albumin in patients on continuous ambulatory peritoneal dialysis - predictors and correlations with outcomes. J Am Soc Nephrol 1993; 3(8):1501-7.
18. Teehan BP, Schleifer CR, Brown JM, Sigler MH, Raimondo J. Urea kinetic analysis and clinical outcome on CAPD. A five year longitudinal study. In: Khanna R, Nolph KD, Prowant BF, Twardowski ZJ, Oreopoulos DG, eds. Advances in peritoneal dialysis. Toronto: Peritoneal Dialysis Bulletin, 1990; 6:181-5.
19. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. J Am Soc Nephrol 1996; 7(2):198-207.
20. Spiegel DM, Anderson M, Campbell U, Hall K, Kelly G, McClure E, et al. Serum albumin: A marker of morbidity in peritoneal dialysis patients. Am J Kidney Dis 1993; 21(1):26-30.
21. Kaysen GA, Schoenfeld PY. Albumin homeostasis in patients undergoing continuous ambulatory peritoneal dialysis. Kidney Int 1984; 25(1): 107-14.
22. Yeun JY, Kaysen GA. Active phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin in peritoneal dialysis patients. Am J Kidney Dis 1997; 30(6):923-7.
23. Haubitz M, Schulze M, Koch KM. Increase of C-reactive protein serum values following hemodialysis. Nephrol Dial Transplant 1990; 5(7):500-3.
24. Sethi D, Muller BR, Brown EA, Maini RN, Gower PE. C-Reactive protein in hemodialysis patients with dialysis arthropathy. Nephrol Dial Transplant 1988; 3(3):269-71.
25. Schindler R, Lonnemann G, Shaldon S, Koch KM, Dinarello CA. Transcription, not synthesis, of interleukin-1 and tumor necrosis factor by complement. Kidney Int 1990; 37(1):85-93.
26. Schindler R, Linnenweber S, Schulze M, Oppermann M, Dinarello CA, Shaldon S, et al. Gene expression of interleukin-1β during hemodialysis. Kidney Int 1993; 43(3):712-21.
27. Lonnemann G, Bingel M, Koch KM, Shaldon S, Dinarello CA. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lymphokine Res 1987; 6(2):63-70.
28. Haeffner-Cavaillon N, Cavaillon JM, Ciancioni C, Bacle F, Delons S, Kazatchkine MD. In vivo induction of interleukin-1 during hemodialysis. Kidney Int 1989; 35(5):1212-18.
29. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B. Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int 1996;49(2):506-11
30. Carozzi S, Nasini MG, Schelotto C, Caviglia PM, Canepa M, Zanin T, et al. Peritoneal macrophage beta-2 microglobulin production and bacterial peritonitis in CAPD patients. ASAIO Trans 1990; 36(3):M369-71.
31. Fieren MW, van den Bernd GJ, Bonta IL. Peritoneal macrophages from patients on continuous ambulatory peritoneal dialysis show a differential secretion of prostanoids and interleukin-1 beta. Prostaglandins Leukot Essent Fatty Acids 1992; 47(1):23-8.
32. Kimmel PL, Philipps TM, Phillips E, Bosch JP. Effect of renal replacement therapy on cellular cytokine production in patients with renal disease. Kidney Int 1990; 38(1):129-35.
33. Nakahama H, Tanaka Y, Shirai D, Miyazaki M, Imai N, Yokokawa T, et al. Plasma interleukin-6 levels in continuous ambulatory peritoneal dialysis and hemodialysis patients. Nephron 1992; 61(2):132-4.
34. Goldman M, Vandenabeele P, Moulart J, Amraoui Z, Abramowicz D, Nortier J, et al. Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 1990; 56(3):277-80.
35. Lin CY, Lin CC, Huang TP. Serial changes of interleukin-6 and interleukin-8 levels in drain dialysate of uremic patients with continuous ambulatory peritoneal dialysis during peritonitis. Nephron 1993; 63(4):404-8.
36. Haubitz M, Brunkhorst R, Wrenger E, Froese P, Schulze M, Koch KM. Chronic induction of C-reactive protein by hemodialysis, but not by peritoneal dialysis therapy. Perit Dial Int 1996; 16(2):158-62.
37. Qureshi AR, Anderstam B, Danielsson A, Gutierrez A, Lindholm B, Bergström J. Predictors of malnutrition in maintenance hemodialysis (HD) patients (Abstract). J Am Soc Nephrol 1995; 6:586.
38. Hind CRK, Thomson SP, Winearls CG, Pepys MB. Serum C-reactive protein concentration in the management of infection in patients treated by continuous ambulatory peritoneal dialysis. J Clin Pathol 1985; 38(4):459-63
39. Grau AJ, Buggle F, Becher H, Werle E, Hacke W. The association of leukocyte count, fibrinogen and C-reactive protein with vascular risk factors and ischemic vascular diseases. Thromb Res 1996; 82(3):245-55.
40. Kaysen GA, Rathore V, Shearer GC, Depner T. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 1995; 48(2):510-16.
41. Qureshi AR, Alvestrand A, Danielsson A, Divino-Filho JC, Gutierrez A, Lindholm B, et al. Factors predicting malnutrition in hemodialysis patients: a cross-sectional study. Kidney Int 1998; 53(3):773-82.
42. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Arisz L. The effect of serum albumin at the start of continuous ambulatory peritoneal dialysis treatment on patient survival. Perit Dial Int 1994; 14(2):121-6.
43. Davies SJ, Russell L, Bryan J, Phillips L, Russell GI. Comorbidity, urea kinetics, and appetite in continuous ambulatory peritoneal dialysis patients: their interrelationship and prediction of survival. Am J Kidney Dis 1995; 26(2):353-61.
44. Barrett BJ, Parfrey PS, Morgan J, Barre P, Fine A, Goldstein MB, et al. Prediction of early death in end-stage renal disease patients starting dialysis. Am J Kidney Dis 1997; 29(2):214-22.
45. Maiorca R, Vonesh EF, Cavalli P, De Vecchi A, Giangrande A, La Greca G, et al. A multicenter, selection-adjusted comparison of patient and technique survivals on CAPD and hemodialysis. Perit Dial Int 1991; 11(2):118-27.
46. McMillan DE. Increased levels of acute-phase serum proteins in diabetes. Metabolism 1989; 38(11): 1042-6.